Thyroid hormones influence all major metabolic pathways. Their most obvious
and well-known action is an increase in basal energy expenditure obtained
acting on protein, carbohydrate and lipid metabolism. With specific regard
to lipid metabolism, thyroid hormones affect synthesis, mobilization and de
gradation of lipids, although degradation is influenced more than synthesis
. The main and best-known effects on lipid metabolism include: (a) enhanced
utilization of lipid substrates; (b) increase in the synthesis and mobiliz
ation of triglycerides stored in adipose tissue; (c) increase in the concen
tration of non-esterified fatty acids (NEFA); and (d) increase of lipoprote
in-lipase activity. While severe hypothyroidism is usually associated with
an increased serum concentration of total cholesterol and atherogenic lipop
roteins, the occurrence of acute myocardial infarction (AMI) in hypothyroid
patients is not frequent, However, hypothyroid patients appear to have an
increased incidence of residual myocardial ischemia following AMI. Even in
subclinical hypothyroidism, which is characterized by raised serum TSH leve
ls with normal serum thyroid hormone concentrations, mild hyperlipidemia is
present and may contribute to an increased risk of atherogenesis. Prudent
substitution therapy with L-thyroxine is indicated in patients with both ov
ert and subclinical hypothyroidism, with or without angina, to counteract t
he cardiovascular risk resulting from hyper-dyslipidemia.